Please provide your email address to receive an email when new articles are posted on . Initiating ivabradine before discharge among patients with stabilized HF increased ivabradine use at 180 days ...

Please provide your email address to receive an email when new articles are posted on . BARCELONA, Spain — The addition of ivabradine to standard background therapy to reduce heart rate did not ...

Ivabradine is indicated to reduce the risk of hospitalisation for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with reduced left ventricular ejection ...

Ivabradine did not reduce the occurrence of myocardial injury after noncardiac surgery (MINS), according to late-breaking research presented in a Hot Line session today at ESC Congress 2025. MINS is a ...

SILVER SPRING, MD — Response to the recent approval of the heart-rate–slowing drug ivabradine (Corlanor, Amgen) by the US Food and Drug Administration (FDA) has included cautious enthusiasm as well as ...

Patients with postural orthostatic tachycardia syndrome treated with ivabradine have better heart-rate control when standing. HealthDay News — Ivabradine lowers heart rate (HR) and relieves symptoms ...

(HealthDay News) — For patients with angina pectoris, ivabradine is associated with improvements in certain parameters of quality of life (QoL), according to a study published online in Circulation: ...

The ASSOCIATE study investigators have reported that the I f current inhibitor, ivabradine, is safe, improves exercise performance, and delays the development of ischemia in patients with chronic ...

Raised heart rate is not only a marker of risk. There is increasing evidence that it is also a modifiable risk factor – that lowering a raised heart rate is associated with improved outcomes – ...

The appraisal committee reviewed the data available on the clinical and cost effectiveness of ivabradine, having considered evidence on the nature of chronic heart failure and the value placed on the ...

A pill costing less than £1.50 a day has the potential to save the lives of thousands of heart failure patients, medical trials suggest. The drug, ivabradine, is already available in the UK to treat ...